InsiderClue
Stocks · Health care · Pharmaceutical Preparations

SCYNEXIS INC

SCYX Clue Score60
United States Fiscal year ends December CIK 0001178253
$4.08 -3.32% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $4.08 −23.88% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2016Revenue0.3Operating income−27.8Net income−30.0EPS, diluted−1.58Fiscal year 2017Revenue0.3 +0.0%Operating income−26.3Net income−25.1Fiscal year 2018Revenue0.3 +0.0%Operating income−30.0Net income−12.5Fiscal year 2019Revenue0.1 −52.9%Operating income−48.9Net income−53.7Fiscal year 2020Revenue0.0 −100.0%Operating income−51.1Net income−55.2Fiscal year 2021Revenue13.2Operating income−60.8Net income−32.9EPS, diluted−1.25Fiscal year 2022Revenue5.1 −61.3%Operating income−85.8Net income−62.8EPS, diluted−1.47Fiscal year 2023Revenue140.1 +2,652.7%Operating income72.7Net income67.0EPS, diluted1.39Fiscal year 2024Revenue3.7 −97.3%Operating income−37.1Net income−21.3 −131.8%EPS, diluted−0.44Fiscal year 2025Revenue20.6 +449.9%Operating income−16.1Net income−8.6EPS, diluted−0.17
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 0.3 0.3 0.3 0.1 0.0 13.2 5.1 140.1 3.7 20.6
Growth +0.0% +0.0% −52.9% −100.0% −61.3% +2,652.7% −97.3% +449.9%
Operating income −27.8 −26.3 −30.0 −48.9 −51.1 −60.8 −85.8 72.7 −37.1 −16.1
Net income −30.0 −25.1 −12.5 −53.7 −55.2 −32.9 −62.8 67.0 −21.3 −8.6
Growth −131.8%
EPS, diluted −1.58 n/a n/a n/a n/a −1.25 −1.47 1.39 −0.44 −0.17

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2016Operating margin−10,823.7%Net margin−11,668.9%Free cash flow margin−11,431.9%Fiscal year 2017Operating margin−10,241.2%Net margin−9,751.0%Free cash flow margin−9,555.6%Fiscal year 2018Operating margin−11,666.5%Net margin−4,851.4%Free cash flow margin−11,240.5%Fiscal year 2019Operating margin−40,430.6%Net margin−44,388.4%Free cash flow margin−31,503.3%Fiscal year 2020Fiscal year 2021Operating margin−462.2%Net margin−249.7%Free cash flow margin−414.5%Fiscal year 2022Operating margin−1,684.5%Net margin−1,233.7%Fiscal year 2023Operating margin51.9%Net margin47.8%Fiscal year 2024Operating margin−990.8%Net margin−568.3%Fiscal year 2025Operating margin−78.0%Net margin−41.8%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating margin −10,823.7% −10,241.2% −11,666.5% −40,430.6% n/a −462.2% −1,684.5% 51.9% −990.8% −78.0%
Net margin −11,668.9% −9,751.0% −4,851.4% −44,388.4% n/a −249.7% −1,233.7% 47.8% −568.3% −41.8%
Free cash flow margin −11,431.9% −9,555.6% −11,240.5% −31,503.3% n/a −414.5% n/a n/a n/a n/a

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2016Operating cash flow−29.4Capital expenditure−0.0Free cash flow−29.4Fiscal year 2017Operating cash flow−24.6Capital expenditure−0.0Free cash flow−24.6Fiscal year 2018Operating cash flow−28.3Capital expenditure−0.6Free cash flow−28.9Fiscal year 2019Operating cash flow−38.1Capital expenditure0.0Free cash flow−38.1Fiscal year 2020Operating cash flow−49.4Capital expenditure−0.0Free cash flow−49.4Fiscal year 2021Operating cash flow−54.6Capital expenditure0.0Free cash flow−54.6Fiscal year 2022Operating cash flow−79.9Fiscal year 2023Operating cash flow60.2Fiscal year 2024Operating cash flow−24.0Fiscal year 2025Operating cash flow−5.3
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −29.4 −24.6 −28.3 −38.1 −49.4 −54.6 −79.9 60.2 −24.0 −5.3
Capital expenditure −0.0 −0.0 −0.6 0.0 −0.0 0.0 n/a n/a n/a n/a
Free cash flow −29.4 −24.6 −28.9 −38.1 −49.4 −54.6 n/a n/a n/a n/a
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2016Cash35.7Total debt14.3Net cash (debt)21.4Shareholders’ equity34.8Debt to equity0.41Fiscal year 2017Cash11.5Total debt14.7Net cash (debt)−3.2Shareholders’ equity21.4Debt to equity0.68Fiscal year 2018Cash11.4Total debt15.1Net cash (debt)−3.6Shareholders’ equity31.2Debt to equity0.48Fiscal year 2019Cash41.9Total debt0.0Net cash (debt)41.9Shareholders’ equity12.9Debt to equity0.00Fiscal year 2020Cash93.0Shareholders’ equity22.8Fiscal year 2021Cash104.5Total debt34.4Net cash (debt)70.1Shareholders’ equity41.3Debt to equity0.83Fiscal year 2022Cash45.8Shareholders’ equity3.2Fiscal year 2023Cash34.1Shareholders’ equity73.0Fiscal year 2024Cash16.1Shareholders’ equity55.1Fiscal year 2025Cash21.3Shareholders’ equity49.4
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 35.7 11.5 11.4 41.9 93.0 104.5 45.8 34.1 16.1 21.3
Total debt 14.3 14.7 15.1 0.0 n/a 34.4 n/a n/a n/a n/a
Net cash (debt) 21.4 −3.2 −3.6 41.9 n/a 70.1 n/a n/a n/a n/a
Shareholders’ equity 34.8 21.4 31.2 12.9 22.8 41.3 3.2 73.0 55.1 49.4
Debt to equity 0.41 0.68 0.48 0.00 n/a 0.83 n/a n/a n/a n/a

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Dec 2016 FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022† 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Revenue and profit
0.3 0.3 0.3 0.1 0.0 13.2 5.1 140.1 3.7 20.6
Growth +0.0% +0.0% −52.9% −100.0% −61.3% +2,652.7% −97.3% +449.9%
20.1 18.3 21.6 38.4 36.5 23.8 27.3 30.9 26.4 22.3
8.0 8.3 8.7 10.6 14.6 49.9 63.0 20.9 14.5 14.4
−27.8 −26.3 −30.0 −48.9 −51.1 −60.8 −85.8 72.7 −37.1 −16.1
Growth −151.1%
−30.0 −25.1 −19.2 −53.7 −58.3 −36.0 −67.5 67.2 −21.1 −8.6
0.0 0.0 −6.7 0.0 −3.1 −3.1 −4.7 0.1 0.2 0.0
−30.0 −25.1 −12.5 −53.7 −55.2 −32.9 −62.8 67.0 −21.3 −8.6
Growth −131.8%
Per share
−1.58 −0.94 −0.28 −0.96 n/a −1.25 −1.47 1.40 −0.44 −0.17
−1.58 n/a n/a n/a n/a −1.25 −1.47 1.39 −0.44 −0.17
Growth −131.7%
19.0 n/a n/a n/a n/a 26.4 42.6 47.9 48.5 49.9
19.0 n/a n/a n/a n/a 26.4 42.6 48.4 48.5 49.9
Growth +61.5% +13.6% +0.3% +2.9%

† The diluted share count jumps at 2022, so per-share figures either side of that column are not comparable. Usually a split, but the break lands on the restatement boundary rather than on the split date, because every column is that period’s latest filing.

Five years in brief

Worked out from the figures above, not from a press release
  • A net loss in 9 of 10 years on file.